作者
Timothy Caulfield, Sarah Burningham, Yann Joly, Zubin Master, Mahsa Shabani, Pascal Borry, Allan Becker, Michael Burgess, Kathryn Calder, Christine Critchley, Kelly Edwards, Stephanie M Fullerton, Herbert Gottweis, Robyn Hyde-Lay, Judy Illes, Rosario Isasi, Kazuto Kato, Jane Kaye, Bartha Knoppers, John Lynch, Amy McGuire, Eric Meslin, Dianne Nicol, Kieran O’Doherty, Ubaka Ogbogu, Margaret Otlowski, Daryl Pullman, Nola Ries, Chris Scott, Malcolm Sears, Helen Wallace, Ma'n H Zawati
发表日期
2014/3/1
来源
Journal of Law and the Biosciences
卷号
1
期号
1
页码范围
94-110
出版商
Oxford University Press
简介
Biobanks 1 have emerged as a significant research tool, gaining support from both the scientific community and regional, national and international research funding agencies. However, developing and maintaining these platforms is expensive. Indeed, in a recent survey of operational personnel representing 456 biobanks, funding shortages concerned 71% of those surveyed and 37% identified ‘funding’as ‘the biobank’s greatest challenge.’2 Thus, unsurprisingly, biobanks may seek support from the private sector or philanthropic organizations, which have an interest in sustaining them as research resources.
The scientific community is also increasingly facing pressure to commercialize and translate their work, thus increasing expectations of industry partnerships. 3 Funding agencies, in part, create and reinforce this commercialization pressure, by earmarking grants for projects that aim to bring products and …
学术搜索中的文章
T Caulfield, S Burningham, Y Joly, Z Master, M Shabani… - Journal of Law and the Biosciences, 2014